Renle Du
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Cells and Metastasis 4
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Wenzhi Shen (13 shared papers)Rong Xiang (9 shared papers)Na Luo (7 shared papers)Wenjuan Gao (4 shared papers)Xiaoyuan Zhang (5 shared papers)Shuangtao Zhao (6 shared papers)Na Li (2 shared papers)Wei Zhou (2 shared papers)
- Journals
- British Journal of Cancer (3 papers)Signal Transduction and Targeted Therapy (2 papers)Theranostics (2 papers)Cancer Medicine (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesMontenegro
In The Last Decade
Renle Du
23 papers receiving 475 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 89
- Immunology 104
- Oncology 122
- Molecular Biology 215
- Biotechnology 17
Countries citing papers authored by Renle Du
This map shows the geographic impact of Renle Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renle Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renle Du more than expected).
Fields of papers citing papers by Renle Du
This network shows the impact of papers produced by Renle Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renle Du. The network helps show where Renle Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Renle Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2019 | 44 | |
| 3 | 2024 | 39 | |
| 4 | 2016 | 35 | |
| 5 | 2020 | 35 | |
| 6 | 2018 | 34 | |
| 7 | 2019 | 33 | |
| 8 | 2020 | 33 | |
| 9 | 2019 | 27 | |
| 10 | 2019 | 20 | |
| 11 | 2018 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2018 | 17 | |
| 14 | 2019 | 13 | |
| 15 | 2021 | 10 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 4 |
About Renle Du
Renle Du is a scholar working on Oncology, Immunology, Biotechnology, Hepatology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 480 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), TGF-β signaling in diseases (2 papers), Cancer Mechanisms and Therapy (2 papers), Immunotherapy and Immune Responses (2 papers), Bone and Dental Protein Studies (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (89 citations), Immunology (104 citations), Oncology (122 citations), Molecular Biology (215 citations) and Biotechnology (17 citations). Renle Du has collaborated with scholars based in China, United States and Montenegro. Frequent co-authors include Wenzhi Shen, Rong Xiang, Na Luo, Wenjuan Gao, Xiaoyuan Zhang, Shuangtao Zhao, Na Li, Wei Zhou, Wancai Yang and Juan Wang. Their work appears in journals such as British Journal of Cancer, Signal Transduction and Targeted Therapy, Theranostics, Cancer Medicine and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.